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We have recently observed that chitotriosidase, a
chitinolytic enzyme, is secreted by activated human
macrophages and is markedly elevated in plasma of
Gaucher disease patients (Hollak, C. E. M., van Weely, S.,
van Oers, M. H. J., and Aerts, J. M. F. G. (1994) J. Clin.
Invest. 93, 1288–1292). Here, we report on the cloning of
the corresponding cDNA. The nucleotide sequence of
the cloned cDNA predicts a protein with amino acid
sequences identical to those established for purified chi-
totriosidase. Secretion of active chitotriosidase was ob-
tained after transient transfection of COS-1 cells with
the cloned cDNA, confirming its identity as chitotriosi-
dase cDNA. Chitotriosidase contains several regions
with high homology to those present in chitinases from
different species belonging to family 18 of glycosyl hy-
drolases. Northern blot analysis shows that expression
of chitotriosidase mRNA occurs only at a late stage of
differentiation of monocytes to activated macrophages
in culture. Our results show that, in contrast to previous
beliefs, humanmacrophages can synthesize a functional
chitinase, a highly conserved enzyme with a strongly
regulated expression. This enzymemay play a role in the
degradation of chitin-containing pathogens and can be
used as a marker for specific disease states.
Chitinases are known to occur in a variety of species, includ-
ing bacteria, fungi, nematodes, plants, insects, and fish (1). It
has often been suggested that man and other mammals do not
possess an analogous chitinase (2, 3). We have recently re-
ported on the existence of a chitinolytic enzyme in man, desig-
nated as chitotriosidase, which is secreted in large quantities
by activated macrophages (4). Both N-terminal and internal
amino acid sequences of purified chitotriosidase suggest a ho-
mology with proteins of the chitinase family, including enzy-
matically inactive members (5).
The enzyme chitotriosidase is also of interest for clinical
reasons. Chitotriosidase activity is several hundred-fold ele-
vated in plasma of patients suffering from Gaucher disease, a
disorder characterized by the presence of large amounts of
activated, lipid-laden macrophages in spleen, liver, and other
tissues (4). More modest elevations are found in plasma of
patients with sarcoidosis and leishmaniasis (4). The enzyme
can therefore serve as a valuable diagnostic marker particu-
larly for Gaucher disease and may be useful in monitoring the
efficacy of therapy. Furthermore, evidence has been obtained
that a genetic deficiency of chitotriosidase occurs with high
frequency in man; the nature and consequence of this defect is
not yet known (4).
To obtain more insight into the structural features and reg-
ulation of the expression of human chitotriosidase, we have
cloned the corresponding full-length cDNA. This enabled us to
compare the derived primary structure of chitotriosidase with
that of other proteins of the chitinase family and to monitor the
expression of chitotriosidase mRNA in a model system consist-
ing of cultured human peripheral blood monocytes differenti-
ating into activated macrophages. The results are described in
this paper.
MATERIALS AND METHODS
In Vitro Differentiation of Peripheral Blood Monocytes to Macro-
phages—Human peripheral blood monocytes were isolated and cultured
as described (4). Spontaneous differentiation of monocytes into acti-
vated macrophages occurs upon prolonged cell culture (4).
Polymerase Chain Reaction Amplification of a Chitotriosidase cDNA
Probe—Total RNA was isolated from cultured macrophages that se-
creted large amounts of chitotriosidase activity as described (6, 7). First
strand cDNA synthesis was performed on 15 mg of total RNA using
SuperScriptTM RNase H2 reverse transcriptase (Life Technologies, Inc.)
and oligo(dT). After alkaline hydrolysis, the cDNA was precipitated
with ethanol and used as template for polymerase chain reaction
(PCR)1 amplification with degenerate chitotriosidase primers. Primers,
manufactured by Pharmacia, were as follows: 59-TGYTAYTTYAC-
NAAYTGGGC-39 (N-terminal derived sense primer) and 59-CCART-
CIARRTYIAVICCRTCRAA-39 (an antisense primer designed on the
basis of homology within the chitinase family). PCR was performed
using standard conditions except for annealing at 48 °C. After 25 cycles
a DNA fragment of the expected size was obtained, and subsequently
the fragment was purified, treated with T4 DNA polymerase (Pharma-
cia, Uppsala, Sweden), and cloned into the HincII site of plasmid
pUC19. DNA sequence analysis was performed using the dideoxy-nu-
cleotide chain termination method with T7 polymerase (Pharmacia)
and the M13 forward and reverse primers (New England Biolabs,
Beverly, MA) as described (7, 8). The cloned PCR fragment of chitotrio-
sidase was used as probe in the cDNA library screening.
Isolation of a Full-length Chitotriosidase cDNA from a Macrophage
cDNA Library—Double-stranded macrophage cDNAwas prepared from
total macrophage RNA using the SuperScript Choice System cDNA
synthesis kit (Life Technologies, Inc.) according to the manufacturer’s
protocol. Double-stranded cDNA was ligated to an excess of non-palin-
dromic BstXI linkers and subsequently size fractionated on a low melt-
ing-type agarose gel, cDNA exceeding 500 base pairs was purified and
ligated into the BstXI sites of the vector pcDNA1 (Invitrogen). The
ligation mixture was electroporated into Escherichia coli strain
MC1063/p3 to obtain a macrophage cDNA library. The cDNA library
was screened by colony hybridization using the partial chitotriosidase
cDNA probe, which had been radiolabeled with 32P by the random
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priming method (7). Hybridization to the radiolabeled probe was carried
out for 4 h in 1 mM EDTA, 0.5 M NaHPO4, pH 7.2, and 7% SDS at 65 °C.
Subsequently, the filters were washed twice in 1 3 SSC (150 mM NaCl,
15 mM sodium citrate, pH 7.0) containing 0.1% SDS and subjected to
autoradiography. The positive clones were sequenced as described
above.
Computer Analysis—Nucleotide and amino acid homology searches
were carried out using the program BLAST (Basic Local Alignment
Search Tool (9)). Sequence analysis of cDNA clones was performed
using Mac Vector 4.1.1 and the Genetics Computing Group package
(version 7.0). Sequence comparisons and multiple sequence alignments
of members of the chitinase family of proteins were performed using the
multiple sequence alignment program PILEUP and BESTFIT.
Activity Measurement of Recombinant Chitotriosidase—Transient
transfection of COS-1 cells by the DEAE-Dextran method was per-
formed essentially as described in Ref. 10. The activity of chitotriosidase
was measured using the fluorogenic substrate 4-methylumbelliferyl
b-D-N,N9,N0-triacetylchitotriose (Sigma) exactly as described before (4).
For the experiments, medium from transfected COS cells was collected,
and cells were harvested. Transfected COS cells were harvested by
trypsinization and extracted by sonication in 0.25% (v/v) Triton X-100,
50 mM potassium phosphate buffer (pH 6.5). The homogenate was
centrifuged, and the supernatant was collected.
Northern Blot Analysis—Total macrophage RNA was isolated using
RNAzol B (Biosolve, Barneveld, The Netherlands) according to the
instructions of the manufacturer. Samples (20 mg) were electrophoresed
in 10 mM Hepes, 6% formaldehyde-agarose gels, transferred to Hybond
N nylon membranes (Amersham, Buckinghamshire, United Kingdom)
by the capillary method, and immobilized by UV cross-linking. The
following 32P-radiolabeled probes were used: total chitotriosidase
cDNA, a PCR fragment of type 5, tartrate-resistant acid phosphatase
cDNA, and mouse glyceraldehyde-3-phosphate-dehydrogenase cDNA.
Hybridization conditions were as described above for the library screen-
ing. The signals on the membranes were quantitated using a Phosphor-
Imager (Molecular Dynamics).
RESULTS
Strategy for the Molecular Cloning of the Chitotriosidase
cDNA—First, a probe to identify chitotriosidase cDNA was
generated. The previously established N-terminal amino acid
sequence of chitotriosidase was used to design a degenerate
sense oligonucleotide. A degenerate antisense oligonucleotide
was designed on the basis of a highly conserved domain in the
chitinase family. These oligonucleotides were used to amplify a
DNA fragment by reverse transcriptase-PCR using total RNA
isolated from cultured macrophages as template. The resulting
DNA fragment was of the expected size (on the basis of homol-
ogy with members of the chitinase family) and was cloned into
the plasmid vector pUC19. Determination of its sequence re-
vealed that the fragment was in complete accordance with the
known N-terminal amino acid sequence of purified human chi-
totriosidase (5), allowing its use as a probe to identify a full-
length chitotriosidase cDNA.
A cDNA library was prepared using total RNA from cultured
macrophages. About 0.1% of the colonies were positive upon
hybridization with the probe. One of them had an insert of 1.7
kilobase pairs, which is large enough to contain the complete
coding information for chitotriosidase. The nucleotide sequence
of this cloned cDNA revealed an open reading frame of 1398
base pairs long, starting with an ATG codon at position 13 and
ending with a TGA codon at position 1410 (Fig. 1). The open
reading frame encodes a protein with a characteristic N-termi-
nal 21 amino acids endoplasmic reticulum signal peptide im-
mediately followed by the N-terminal sequence established for
the chitotriosidase protein (5). The cDNA sequence does not
indicate the presence of potential N-linked glycosylation sites,
which is consistent with the absence of N-linked glycans in
isolated chitotriosidase (5). The predicted protein, after re-
moval of the signal sequence, has a length of 445 amino acids
and a calculated molecular mass of 49 kDa, thus corresponding
to the larger of the two major isoforms of chitotriosidase iso-
lated previously from Gaucher spleen.
Homology with Other Proteins—A search of the EMBL and
GenBank data bases revealed significant homology with a
group of chitinases and related proteins from different species
(see Fig. 1). The strongest homology was observed with a re-
cently published cDNA sequence, for a chitinase-related hu-
man cartilage glycoprotein (11), and with a cDNA sequence
coding for a secretory protein from activated mouse macro-
phages (GenBank accession no. M94584). These two proteins
have no chitinolytic activity, and their function is not known
(Ref. 11 and GenBank accession no. M94584). The human
chitotriosidase cDNA sequence indicates the presence of a re-
gion that is highly homologous to the presumed catalytic center
in chitinases (Fig. 2; see Ref. 15).
A comparison with amino acid sequences of members of the
chitinase family, also including the enzymatically inactive pro-
teins, reveals additional homologous regions. In Fig. 1, the
amino acids in chitotriosidase that are identical to those in at
least six out of nine members of the chitinase protein family are
indicated by bold characters.
The predicted C-terminal part of human chitotriosidase
shows only homology with two members of this family,
Manduca sexta (13) and Brugia malayi chitinases (14). The
homologous C-terminal stretches in these chitinases are char-
acterized by the abundant presence of serine residues that
might be modified by glycosylation. In the case of the B. malayi
chitinase, O-linked glycosylation has indeed been
demonstrated (14).
Functional Expression of Chitotriosidase in COS Cells—Ex-
pression of chitotriosidase upon transient transfection of
COS-1 cells with the full-length chitotriosidase cDNAwas mon-
itored by detection of enzyme activity. At day 7 post-transfec-
tion, chitotriosidase activity was present in the medium of the
transfected COS cells. No activity was detectable in mock-
transfected COS cells or cells transfected with the same cDNA
inserted in the antisense orientation. This enzyme activity
produced by transfected COS cells could be inactivated in an
identical manner as splenic chitotriosidase, with a rabbit poly-
clonal antiserum raised against purified human tissue chito-
triosidase (data not shown).
Expression of Chitotriosidase mRNA in Monocyte-derived
Macrophages—Northern blot analysis with the chitotriosidase
and tartrate-resistant acid phosphatase cDNA probes was used
to investigate mRNA expression during differentiation of cul-
tured blood monocytes into macrophages (see Fig. 3). Tartrate-
resistant acid phosphatase mRNA, a differentiation marker for
macrophages, was already detectable after 2 days of culture
and gradually increased in time, reaching a maximum level at
14 days of culture (panel A). During the first 4 days of culture,
chitotriosidase mRNA was not detectable. Only at day 7,
mRNA for chitotriosidase became detectable and increased
markedly in time. Even at the end of the experiment, day 22 of
culture, a steady state level of chitotriosidase mRNA had not
been reached (panel B). This time dependence is similar to that
observed for the production of chitotriosidase activity in the cell
culture model (see Ref. 4).
DISCUSSION
Several lines of evidence show that the isolated cDNA clone
encodes chitotriosidase. First, N-terminal and internal peptide
sequences of purified tissue chitotriosidase are present in the
protein sequence derived from the cloned cDNA. Second, trans-
fection of COS-1 cells with the cDNA results in the synthesis
and secretion of an enzymatically active chitinase that, like
splenic chitotriosidase, is inactivated by antiserum raised
against the tissue enzyme. Furthermore, we observed that the
relative rate of hydrolysis of the artificial substrates 4-methyl-
umbelliferyl-chitotrioside and 4-methylumbelliferyl-chitobio-
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side was identical for tissue chitotriosidase and enzyme pro-
duced by COS cells (data not shown). Finally, the absence of
N-linked glycans in chitotriosidase is predicted by the cDNA
sequence, which is consistent with the results of our previous
investigations on purified chitotriosidase (5).
The results of our study imply that there is a gene in man
encoding a chitinolytic enzyme homologous to chitinases from
various other species, in particular with respect to the region
that is assumed to be an essential part of the catalytic site (15).
Strong homologies between the human enzyme and other chiti-
nases are also noted for various other regions that might be
crucial to generate the characteristic conformation of this type
of enzyme.
The extensive homology between human and other chiti-
nases is interesting and may have important clinical implica-
tions. For instance, the use of parasite chitinase fragments as
vaccine targets has been proposed (1, 16). It may be advisable
to use only non-homologous regions of parasite chitinases for
vaccination to prevent a potential immunological response to
the endogenous human counterpart.
On the basis of its sequence homology with other chitinases,
the human chitotriosidase should be considered to belong to
family 18 of glycosyl hydrolases (17). It has recently been
proposed that the catalytic core structure of family 18 of gly-
cosyl hydrolases is an 8-stranded a/b (TIM) barrel (18). Al-
though some plant endochitinases and lysozyme belong to a
family of glycosyl hydrolases distinct from family 18, we have
observed some similarities between human chitotriosidase and
lysozyme (19). For instance, chitotriosidase, like lysozyme, is
relatively heat stable and resistant to proteolytic degradation.
FIG. 1. Chitotriosidase cDNA se-
quence and deduced amino acid se-
quence. The hydrophobic leader peptide
(amino acids 1–21) is underlined. Amino
acids in chitotriosidase that are identical
to those in at least six out of nine mem-
bers of the chitinase family are depicted
in bold characters. The nine members of
the chitinase family used are listed in the
legend of Fig. 2, with the exception of
Autographa californica chitinase and
Nicotiana tabacum chitinase. The
stretches of amino acids that are also
identified in splenic enzyme are under-
lined with dots (5). The putative poly-
adenylation signal is indicated in bold.
The chitotriosidase cDNA sequence has
been deposited in the GenBank data base.
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Chitotriosidase, like lysozyme, is inhibited in activity by high
concentrations of the substrate 4-methylumbelliferyl-chitotrio-
side and shows a very broad pH optimum. Chitotriosidase and
lysozyme are both present in lysosomes and granules of neu-
trophilic granolocytes. Macrophages constitutively secrete both
chitotriosidase and lysozyme and partly accumulate the en-
zymes in their lysosomes.2 The analogies between chitotriosi-
dase and other members of family 18 of glycosyl hydrolases,
and some of its similarities with the well characterized ly-
sozyme, should be helpful in future investigations on structure-
function relationships in chitotriosidase.
Chitotriosidase, unlike most lysosomal hydrolases, is not a
house-keeping enzyme. The macrophages are capable of pro-
ducing very large amounts of the enzyme under specific cir-
cumstances. One such condition is the prolonged culture of
macrophages derived from peripheral blood monocytes. On the
basis of our findings, it may be assumed that chitotriosidase
mRNA comprises approximately 0.1% of the total mRNA in
macrophages cultured for 3 weeks. Metabolic labeling studies
suggest that about 1% of the secretory proteins of these cells is
chitotriosidase. Another condition is found in Gaucher disease,
in which an inherited deficiency in glucocerebrosidase activity
causes lysosomal storage of glucosylceramide in macrophages.
This is accompanied by greatly enhanced levels of chitotriosi-
dase in plasma (4).
The physiological role of the human chitinase still has to be
established. On the basis of its known properties, it seems
likely to fulfill a role in the degradation of chitin-containing
pathogens. The existence of a rather frequent, inherited defi-
ciency in chitotriosidase activity in man and the occurrence of
abnormal high enzyme levels in plasma of Gaucher disease
patients should help to elucidate the physiological role of chi-
totriosidase (4). In this connection, it is interesting to note that
plants are known to produce high amounts of chitinases under
conditions of stress (20, 21). The anti-fungal action of these
proteins in plants is very well documented (22–24). More re-
cently, an additional role in morphogenetic processes in plants
has been postulated (12, 21). The exact function of chitinases in
morphogenesis is not clear, since plants are believed to contain
no endogenous chitin or analogous structures (21). It is con-
ceivable that chitotriosidase in man may also have a dual
function. Alternatively, homologous proteins may be involved
in morphogenetic events in man. The homologous human car-
tilage gp-39 is a 39-kDa glycoprotein that is produced by artic-
ular chondrocytes and synovial cells under specific conditions,
as in rheumatoid arthritis. A role for this protein, which
lacks chitinolytic activity, has been proposed in tissue
remodeling (11).
The demonstration of the existence of a human chitinase
warrants further investigation. The role of chitotriosidase in
defense against specific pathogens has to be carefully examined
as well as the possibility of another physiological function.
Furthermore, the finding that chitotriosidase production is as-
sociated with the presence of specifically stressed macrophages
may be exploited to monitor progression and correction of a
number of pathological conditions in man, such as Gaucher
disease, in which these types of cells are involved.
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